ORPH - hVIVO announces move to good facility at a very good price
(NewsDirect)
hVIVO PLC (AIM:HVO) chief executive MoKhan speaks to Thomas Warner from Proactive after the specialistcontract research organisation announced plans for a newstate-of-the-art consolidated challenge trial facility at the lifesciences hub in Canary Wharf, London.
The expansion, largely funded by hVIVO clients, reflects agrowing order book and increasing demand for its human challenge trialservices, the company said in a statement. The move involves bringingtogether quarantine beds, laboratories, and corporate offices into onefacility. Notably, the new space will accommodate up to 70 quarantinebeds, a significant increase from the previous capacity.
Theenhanced laboratory space will enable more concurrent studies,fostering revenue growth. He notes that hVIVO's "hugelysuccessful screening facilities in Plumbers Row in East London and inManchester will remain at their current locations, but the rest of thecompany will be consolidating into one facility." The phased moveis expected to be completed in Q2 of the coming year and promisesexpanded capabilities, operational efficiency, and sustained growthfor hVIVO.
Contact Details
Proactive UKLtd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.